Nishadil
Ads Astrology Calendar Devs Domains Finance Pay Rewards Weather
Signup Signin
Washington | 13°C (broken clouds)
Topic Feed

Abbvie

Showing the latest stories and updates for this topic.
The Cost of Cures: Unpacking America's Enduring Drug Price Predicament

The Cost of Cures: Unpacking America's Enduring Drug Price Predicament
A Tale of Two Pharma Giants: Wolfe Research Shifts Gears on Merck and AbbVie

A Tale of Two Pharma Giants: Wolfe Research Shifts Gears on Merck and AbbVie
Following the Smart Money: Decoding This Week's Insider Trading Signals

Following the Smart Money: Decoding This Week's Insider Trading Signals
Beyond the Diagnosis: A Filmmaker's Quest to Redefine Life with Blood Cancer

Beyond the Diagnosis: A Filmmaker's Quest to Redefine Life with Blood Cancer
The Shifting Sands of Science: AbbVie Steps Back from Calico's Longevity Quest

The Shifting Sands of Science: AbbVie Steps Back from Calico's Longevity Quest
A New Chapter for Little Stomachs: Ironwood's Linzess Opens Doors for Pediatric IBS Relief

A New Chapter for Little Stomachs: Ironwood's Linzess Opens Doors for Pediatric IBS Relief
A Breath of Fresh Air for Kids Living with IBS-C

A Breath of Fresh Air for Kids Living with IBS-C
The Unstoppable Ascent: How Linzess Propelled Ironwood to Staggering Heights

The Unstoppable Ascent: How Linzess Propelled Ironwood to Staggering Heights
AbbVie's High-Stakes Forecast: A Boost That Still Left the Market Wanting More

AbbVie's High-Stakes Forecast: A Boost That Still Left the Market Wanting More
UK's Controversial Drug Price Hike: Pharma Giants Hit the Brakes on Investment

UK's Controversial Drug Price Hike: Pharma Giants Hit the Brakes on Investment
The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?

The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?
AbbVie Unleashes Future Growth: $70 Million R&D and Manufacturing Hub Breaks Ground in Singapore

AbbVie Unleashes Future Growth: $70 Million R&D and Manufacturing Hub Breaks Ground in Singapore
Soaring Horizons: Cystic Fibrosis Therapeutics Market Set to Skyrocket to $39.15 Billion by 2034

Soaring Horizons: Cystic Fibrosis Therapeutics Market Set to Skyrocket to $39.15 Billion by 2034
Unpacking Today's Top Stock Insights: AbbVie, Vertex, Veeva, and Vistra Under the Microscope

Unpacking Today's Top Stock Insights: AbbVie, Vertex, Veeva, and Vistra Under the Microscope
Breakthrough Hope: AbbVie's Next-Gen Alopecia Drug Shows Staggering Results in Late-Stage Trial

Breakthrough Hope: AbbVie's Next-Gen Alopecia Drug Shows Staggering Results in Late-Stage Trial
Load more..